Fluorinated-NHC transition metal complexes: Leading characters as potential anticancer metallodrugs
Por:
Rufino-Felipe, Ernesto, Colorado-Peralta, Raul, Reyes-Marquez, Viviana, Valdes, Hugo, Morales-Morales, David
Publicada:
1 ene 2021
Resumen:
In the last 20 years, N-Heterocyclic Carbene (NHC) ligands have been ubiquitous in biological and medicinal chemistry. Part of their success lies in the tremendous number of topologies that can be synthesized and thus finely tuned that have been described so far. This is particularly true in the case of those derivatives, including fluorine or fluorinated fragments on their NHC moieties, gaining much attention due to their enhanced biological properties and turning them into excellent candidates for the development of novel metallodrugs. Thus, this review summarizes the development that fluorinated-NHC transition metal complexes have had and their impact on cancer treatment. © 2021 Bentham Science Publishers.
Filiaciones:
Rufino-Felipe, Ernesto:
Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán, Ciudad de México, C.P. 04510, Mexico
Colorado-Peralta, Raul:
Facultad de Ciencias Químicas, Universidad Veracruzana, Oriente 6 1009, Col. Rafael Alvarado, Orizaba, Veracruz, C.P. 94340, Mexico
Reyes-Marquez, Viviana:
Departamento de Ciencias Químico-Biológicas, Universidad de Sonora, Luis Encinas y Rosales s/n, Hermosillo, Sonora, CP 83000, Mexico
Valdes, Hugo:
Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán, Ciudad de México, C.P. 04510, Mexico
Morales-Morales, David:
Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Coyoacán, Ciudad de México, C.P. 04510, Mexico
|